אימנד 150 מ"ג IV

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

FOSAPREPITANT AS FOSAPREPITANT DIMEGLUMINE 150 MG

Verfügbar ab:

MERCK SHARP & DOHME ISRAEL LTD

ATC-Code:

A04AD12

Darreichungsform:

POWDER FOR SOLUTION FOR INFUSION

Verabreichungsweg:

I.V

Hergestellt von:

MERCK SHARP & DOHME B.V, HOLLAND

Therapiegruppe:

APREPITANT

Anwendungsgebiete:

Emend IV 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose Cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

Berechtigungsdatum:

2011-11-01